Well-Differentiated Neuroendocrine Neoplasms - Part 2 - Advances in the management

Expiry Date
: 28/02/2025
CPD Units
: 3.00 Points
Rating
: Not yet rated.

Neuroendocrine neoplasms are a diverse group of tumours that derive from the sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary and gastrointestinal tracts. Part 2 of this review deals with the recent advances in the Management of Well-Differentiated Neuroendocrine Neoplasms (NENs).

Keywords: Neuroendocrine; Neoplasms; cancer; oncology; therapy; Radionuclide; chemotherapy, endocrinology; somatostatin analogues; immunotherapy

Reading material:

Educational Objectives

Educational Aim:
The aim of this article is to review the most recent advances in the management of well-differentiated Neuroendocrine Neoplasms (NENs).

Editor's comments:
Since the source article is very long, it was broken up into two parts. Part 1 deals with the Diagnosis of NENs. This part, Part 2 deals with the Management of NEN’s.

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

  1. Management of Locoregional disease with surgery.
  2. Liver directed therapy.
  3. Treatment of Hormonal syndromes.
  4. Antiproliferation therapy with somatostatin analogues, radionuclide therapy, immunotherapy and chemotherapy.


Instructions for this Module

  • Read the supplied reading material and complete the quiz that follows;
  • You have three attempts to pass the quiz;
  • The pass grade is 70%;
  • You need to pass the quiz to claim your CPD certificate;
  • Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

If you need any assistance to complete this module, please Contact us